CIBRA Capital’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,139,979
Closed -$3.47M 34
2024
Q4
$3.47M Buy
+1,139,979
New +$3.47M 2.36% 12